Pentoxifylline in toxic epidermal necrolysis and Stevens- Johnson syndrome [4]

International Journal of Dermatology

Volumn 38, Issue 11, 1999, Pages 878-879

  Sanclemente, Gloria ^a   De La Roche, Carlos A ^a   Escobar, Carlos E ^a   Falabella, Rafael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; PENICILLIN DERIVATIVE; PENTOXIFYLLINE;

BODY SURFACE; CASE REPORT; CHILD; CLINICAL FEATURE; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; RASH; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; DRUG ERUPTION; PATHOLOGY;

CHILD, PRESCHOOL; DRUG ERUPTIONS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IBUPROFEN; MALE; PENTOXIFYLLINE; STEVENS-JOHNSON SYNDROME;

EID: 0032590017     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Guillaume JC, Roujeau JC, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166-1170.
2. Correia O, Delgado L, Ramos JP, et al. Cutaneous T cell recruitment in toxic epidermal necrolysis. Further evidence of CD8 + lymphocyte involvement. Arch Dermatol 1993; 129: 466-468.
3. Revuz JE, Roujeau JC. Advances in toxic epidermal necrolysis. Semin Cutan Med Surg 1996; 15: 258-266.
4. Paquet P, Nikkels A, Arrese JE, et al. Macrophage and tumor necrosis factor in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 605-608.
5. Bruynzeel I, Van-der-Raaij LM, Stoof TJ, Willemze R. Pentoxifylline inhibits T-cell adherence to keratinocytes. J Invest Dermatol 1995; 104: 1004-1007.
6. Samlaska CP, Winfield EA. Pentoxifylline: clinical review. J Am Acad Dermatol 1994; 30: 603-611.
7. Billingham RE, Streilein JW. Toxic epidermal necrolysis and homologous disease in hamsters. Arch Dermatol 1968; 98: 528-539.
8. Di Perri G, Di Perri IG, Monteiro GB, et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 1995; 171: 1317-1322.
9. Boldt J, Muller M, Heyn S, et al. Influence of long-term continuous intravenous administration of pentoxifylline on endothelial-related coagulation in critically ill patients. Crit Care Med 1996; 24: 940-946.
10. Redondo P, Ruiz-De Erenchun F, Iglesias ME, et al. Toxic epidermal necrolysis. Treatment with pentoxifylline. Br J Dermatol 1994; 130: 688-689.